Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A W Heath

Showing results (11-20 of 44) with videos related to

Pageof 5
Sort By:
Vaccine|January 1, 1992
Cytokines as immunological adjuvantsA W Heath, J H Playfair
AIDS Research and Human Retroviruses|August 1, 1992
The potential of cytokines as adjuvantsA W Heath, J H Playfair
Immunology|February 13, 2001
Functional activity of CD40 antibodies correlates to the position of binding relative to CD154T A Barr, A W Heath
Developments in Biological Standardization|April 29, 1998
A novel method for enhancement of T independent responsesP Dullforce, D Sutton, A W Heath
Tropical Medicine and Parasitology : Official Organ of Deutsche Tropenmedizinische Gesellschaft and of Deutsche Gesellschaft Fur Technische Zusammenarbeit (GTZ)|December 1, 1990
Monoclonal antibodies mediating viable immunofluorescence and protection against Trypanosoma cruzi infectionA W Heath, M S Martins, L Hudson
The Journal of Infectious Diseases|April 14, 2000
Use of herpes simplex virus (HSV) type 1 ISCOMS 703 vaccine for prophylactic and therapeutic treatment of primary and recurrent HSV-2 infection in guinea pigsJ R Simms, A W Heath, R Jennings
Nature Medicine|January 14, 1998
Enhancement of T cell-independent immune responses in vivo by CD40 antibodiesP Dullforce, D C Sutton, A W Heath
Vaccine|March 4, 2000
Therapeutic vaccination against HSV-2: influence of vaccine formulation on immune responses and protection in miceS A Mohamedi, A W Heath, R Jennings
Antiviral Research|March 15, 2001
A comparison of oral and parenteral routes for therapeutic vaccination with HSV-2 ISCOMs in mice; cytokine profiles, antibody responses and protectionS A Mohamedi, A W Heath, R Jennings
Developments in Biological Standardization|April 29, 1998
Adjuvants and delivery systems for viral vaccines--mechanisms and potentialR Jennings, J R Simms, A W Heath
Pageof 5

Showing results (11-20 of 44) with videos related to

Sort By:
Pageof 5
Vaccine|January 1, 1992
Cytokines as immunological adjuvantsA W Heath, J H Playfair
AIDS Research and Human Retroviruses|August 1, 1992
The potential of cytokines as adjuvantsA W Heath, J H Playfair
Immunology|February 13, 2001
Functional activity of CD40 antibodies correlates to the position of binding relative to CD154T A Barr, A W Heath
Developments in Biological Standardization|April 29, 1998
A novel method for enhancement of T independent responsesP Dullforce, D Sutton, A W Heath
Tropical Medicine and Parasitology : Official Organ of Deutsche Tropenmedizinische Gesellschaft and of Deutsche Gesellschaft Fur Technische Zusammenarbeit (GTZ)|December 1, 1990
Monoclonal antibodies mediating viable immunofluorescence and protection against Trypanosoma cruzi infectionA W Heath, M S Martins, L Hudson
The Journal of Infectious Diseases|April 14, 2000
Use of herpes simplex virus (HSV) type 1 ISCOMS 703 vaccine for prophylactic and therapeutic treatment of primary and recurrent HSV-2 infection in guinea pigsJ R Simms, A W Heath, R Jennings
Nature Medicine|January 14, 1998
Enhancement of T cell-independent immune responses in vivo by CD40 antibodiesP Dullforce, D C Sutton, A W Heath
Vaccine|March 4, 2000
Therapeutic vaccination against HSV-2: influence of vaccine formulation on immune responses and protection in miceS A Mohamedi, A W Heath, R Jennings
Antiviral Research|March 15, 2001
A comparison of oral and parenteral routes for therapeutic vaccination with HSV-2 ISCOMs in mice; cytokine profiles, antibody responses and protectionS A Mohamedi, A W Heath, R Jennings
Developments in Biological Standardization|April 29, 1998
Adjuvants and delivery systems for viral vaccines--mechanisms and potentialR Jennings, J R Simms, A W Heath
Pageof 5